A. Menarini Farmaceutica Internazionale SRL (“Menarini”) has become the exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (a fixed-dose combination of canagliflozin and metformin) in the United Kingdom, including Northern Ireland, where the products have obtained Pricing and Reimbursement Approvals.

Registration is now open for Hypo Awareness Week, which returns in just a few months’ time.

Sodium-glucose Cotransporter-2 (SGLT2) inhibitors demonstrated robust clinical effectiveness in older adults with heart failure and type 2 diabetes, latest research shows.

A leading diabetes consultant from Southport and Ormskirk Hospital has been chosen to deliver a prestigious national lecture in recognition of improvements she has delivered in patient care nationally and globally.

A Guildford-based healthcare business handed over a luxury hamper to a team which went the extra mile for a national campaign aimed at reducing insulin errors in hospitals.

Individuals with type 2 diabetes could soon be treated with Metformin and Probucol after researchers have highlighted the positive impact of this drug combination.

A tool developed by Leicester Diabetes Centre to identify those at risk of type 2 diabetes is set to be used in workplaces and communities to ensure more people receive help earlier.

DISN members have been invited to vote for a topic to be discussed at the group meeting being held at this year’s DSN Forum Conference.

The Eden team based at the Leicester Diabetes Centre released a social media video to shine a light on the emotional toll of living with diabetes.

Innovative ways to promote insulin safety across University Hospital Southampton were showcased during a special visit to mark a national diabetes campaign.

A first-of-its-kind accreditation programme to improve the quality of diabetes inpatient care across the UK is set to launch on 31 May 2023.

The QiC team would like to take this opportunity to thank the amazing individuals who are working on the frontline of healthcare, and their supporters.

A national campaign aiming to reduce insulin errors in hospitals and other care settings in the UK and Ireland will return later this month.

More than 70 per cent of health care settings provide staff with appropriate insulin training, the latest National Diabetes Inpatient Safety Audit has identified.

Chris Askew OBE is leaving his role as the Chief Executive of Diabetes UK after eight years in the job.

A diabetes nursing group has published a hybrid closed loop comparison chart to help people living with diabetes choose the most appropriate system for them.

Healthcare professionals are invited to discover safe injection practices in an upcoming online event hosted by an established diabetes company.

Two diabetes professionals are launching an inpatient campaign next month to educate hospital teams caring for people with the condition.

A team of renowned healthcare professionals will form part of the thrilling agenda for the upcoming Trend Diabetes national conferences.

An established diabetes panel and top healthcare experts will form part of the exciting agenda for the first Diabetes Specialist Nurse (DSN) Forum meeting, organisers have announced.